United States : IRELAND develops an MS and arthritis treatment.
Scientists from Trinity College Dublin (TCD) are making a name for themselves after they revealed that they discovered a marvel molecule to aid in the non-invasive treatment of common inflammatory diseases.
Publishing their findings in the medical journal Nature Medicine, their discovery of the molecule labelled MCC950 has been found to suppress the NLRP3 inflammasome , which is an activator of the key process in inflammatory diseases, multiple sclerosis (MS), arthritis, motor neuron disease and Muckle-Wells syndrome.
With universities in Queensland, Michigan, Massachusetts and Bonn, the TCD scientists discovery of the molecule will represent a major development among the medical science community to find treatments, which have so far shown to be either highly ineffective or have major limitations, for these inflammatory diseases.
Their finding confirms that inflammatory diseases all share a common process, even though the part of the body becoming inflamed might differ. This commonality paves the way for a one-fits-all style treatment process.
MCC950 can be taken orally and will be cheaper than the current ineffective protein methods that exists and is taken through injections on a regular basis and will spend less time in the human body thus reducing the risk of side effects.
Dr Rebecca Coll, said MCC950 is blocking what was suspected to be a key process in inflammation. There is huge interest in NLRP3 both among medical researchers and pharmaceutical companies and we feel our work makes a significant contribution to the efforts to find new medicines to limit it.
2015 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 18, 2015|
|Previous Article:||United States : Dassault Systemes launches second SolidWorks application on 3DExperience platform.|
|Next Article:||United States : ARLON Group devote in Grano Alimentos SA.|